Biotechnology: Biological Products (No Diagnostic Substances) Stocks
119 biotechnology: biological products (no diagnostic substances) stocks ranked by market capitalization, page 2 of 3. Updated October 12, 2026.
Today
+3.71%Biotechnology: Biological Products (No Diagnostic Substances) stocks ranked 51–100
| # | Symbol | Company | Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| 51 | DBVT | DBV Technologies S.A. ADR | 9.80 | +2.62% | 324.06K | $615.92M |
| 52 | VALN | Valneva SE ADR | 5.78 | +1.58% | 5.61K | $548.08M |
| 53 | RGNX | REGENXBIO Inc. | 8.07 | -0.25% | 859.29K | $532.73M |
| 54 | ALLO | Allogene Therapeutics Inc. | 1.46 | +4.29% | 10.61M | $504.42M |
| 55 | AUTL | Autolus Therapeutics plc ADR | 1.81 | +2.26% | 1.48M | $481.75M |
| 56 | ENTX | Entera Bio Ltd. | 2.66 | +6.40% | 1.58M | $462.40M |
| 57 | TECX | Tectonic Therapeutic Inc. | 23.33 | +2.55% | 110.71K | $456.09M |
| 58 | AGMB | AgomAb Therapeutics NV ADR | 9.08 | -1.52% | 102.31K | $447.17M |
| 59 | EDIT | Editas Medicine Inc. | 2.90 | +2.11% | 3.09M | $445.38M |
| 60 | EIKN | Eikon Therapeutics Inc. | 7.47 | -0.40% | 288.69K | $404.61M |
| 61 | SCTX | Scribe Therapeutics Inc. | 21.17 | +10.09% | 397.07K | $400.78M |
| 62 | CCCC | C4 Therapeutics Inc. | 3.16 | +10.88% | 2.51M | $388.76M |
| 63 | ZURA | Zura Bio Limited Class A | 4.00 | -3.15% | 1.71M | $383.32M |
| 64 | FENC | Fennec Pharmaceuticals Inc. | 10.71 | +0.75% | 93.46K | $375.57M |
| 65 | SRZN | Surrozen Inc. | 29.69 | +6.15% | 781.38K | $348.96M |
| 66 | AGEN | Agenus Inc. | 7.67 | +1.72% | 710.29K | $346.39M |
| 67 | ARTV | Artiva Biotherapeutics Inc. | 6.94 | +2.06% | 275.94K | $339.30M |
| 68 | XFOR | X4 Pharmaceuticals Inc. | 2.91 | +4.30% | 541.23K | $288.52M |
| 69 | IKT | Inhibikase Therapeutics Inc. | 1.97 | +3.14% | 435.03K | $274.89M |
| 70 | SABS | SAB Biotherapeutics Inc. | 2.98 | +3.11% | 659.61K | $271.14M |
| 71 | PALI | Palisade Bio Inc. | 1.54 | +6.21% | 1.84M | $268.38M |
| 72 | LXEO | Lexeo Therapeutics Inc. | 3.23 | +0.62% | 961.38K | $265.14M |
| 73 | FATE | Fate Therapeutics Inc. | 2.18 | +2.35% | 773.47K | $261.21M |
| 74 | STRO | Sutro Biopharma Inc. | 14.27 | -6.85% | 256.23K | $236.61M |
| 75 | ALEC | Alector Inc. | 2.08 | +2.97% | 3.12M | $232.25M |
| 76 | CGEN | Compugen Ltd. | 2.13 | +0.47% | 123.36K | $201.76M |
| 77 | DTIL | Precision BioSciences Inc. | 6.72 | +4.51% | 263.69K | $185.48M |
| 78 | IPHA | Innate Pharma S.A. ADS | 1.62 | +9.46% | 46.88K | $180.95M |
| 79 | CHRS | Coherus Oncology Inc. | 1.07 | 0.00% | 1.70M | $165.32M |
| 80 | TARA | Protara Therapeutics Inc. | 2.76 | +3.96% | 1.04M | $162.81M |
| 81 | ABOS | Acumen Pharmaceuticals Inc. | 2.14 | +1.90% | 357.54K | $154.76M |
| 82 | VYGR | Voyager Therapeutics Inc. | 2.45 | +3.38% | 694.39K | $150.96M |
| 83 | CRDL | Cardiol Therapeutics Inc. Class A | 1.23 | -5.38% | 1.26M | $149.46M |
| 84 | MOLN | Molecular Partners AG ADR | 3.85 | +1.05% | 5.74K | $147.48M |
| 85 | AVXL | Anavex Life Sciences Corp. | 1.49 | -3.25% | 1.29M | $138.12M |
| 86 | ARMP | Armata Pharmaceuticals Inc. | 3.63 | -5.96% | 100.58K | $134.97M |
| 87 | ENGN | enGene Therapeutics Inc. | 1.73 | -2.81% | 359.13K | $115.94M |
| 88 | LENZ | LENZ Therapeutics Inc. | 3.65 | +3.26% | 625.76K | $114.53M |
| 89 | BDTX | Black Diamond Therapeutics Inc. | 1.83 | +1.10% | 448.97K | $104.86M |
| 90 | ATRA | Atara Biotherapeutics Inc. | 9.48 | +2.71% | 22.15K | $95.16M |
| 91 | CRDF | Cardiff Oncology Inc. | 1.08 | +1.89% | 298.12K | $84.02M |
| 92 | PTHS | Pelthos Therapeutics Inc. | 20.50 | 0.00% | 45.02K | $78.48M |
| 93 | OKYO | OKYO Pharma Limited | 1.42 | +2.16% | 115.50K | $74.52M |
| 94 | GRML | Greenland Mines Ltd. | 5.17 | -12.07% | 3.68M | $69.00M |
| 95 | CSBR | Champions Oncology Inc. | 4.84 | -2.81% | 1.87K | $67.37M |
| 96 | KLRS | Kalaris Therapeutics Inc. | 2.36 | -5.60% | 104.42K | $56.18M |
| 97 | ELOX | Eloxx Pharmaceuticals Inc. | 13.74 | -9.49% | 31.31K | $55.46M |
| 98 | INKT | MiNK Therapeutics Inc. | 10.72 | -2.55% | 16.98K | $54.70M |
| 99 | LONA | LeonaBio Inc. | 5.75 | 0.00% | 66.68K | $54.17M |
| 100 | INMB | INmune Bio Inc. | 1.89 | +3.28% | 91.63K | $52.45M |
Explore more
Prices as of Oct 12, 1:40 AM EDT. Market data is delayed at least 15 minutes and provided for informational purposes only. Not investment advice. Full disclaimer